13 results on '"Sullman, Mark"'
Search Results
2. The burden of Parkinson’s disease in the Middle East and North Africa region, 1990–2019: results from the global burden of disease study 2019
- Author
-
Safiri, Saeid, Noori, Maryam, Nejadghaderi, Seyed Aria, Mousavi, Seyed Ehsan, Sullman, Mark J. M., Araj-Khodaei, Mostafa, Singh, Kuljit, Kolahi, Ali-Asghar, and Gharagozli, Kurosh
- Published
- 2023
- Full Text
- View/download PDF
3. Burden of female breast cancer in the Middle East and North Africa region, 1990–2019
- Author
-
Safiri, Saeid, Noori, Maryam, Nejadghaderi, Seyed Aria, Sullman, Mark J. M., Bragazzi, Nicola Luigi, Almasi-Hashiani, Amir, Mansournia, Mohammad Ali, and Kolahi, Ali-Asghar
- Published
- 2022
- Full Text
- View/download PDF
4. The burden of rheumatic heart disease in the Middle East and North Africa region, 1990−2019.
- Author
-
Safiri, Saeid, Mousavi, Seyed Ehsan, Noori, Maryam, Nejadghaderi, Seyed Aria, Sullman, Mark J.M., Singh, Kuljit, and Kolahi, Ali-Asghar
- Abstract
• Age-standardized point prevalence of RHD was 388.9/100,000 in MENA in 2019. • Highest age-standardized DALY rate of RHD in 2019 was in Afghanistan. • Age-standardized point prevalence of RHD was highest in middle-age group. • Burden of RHD was negatively associated with the SDI over 1990–2019. Rheumatic heart disease (RHD) is a treatable and preventable condition resulting from acute rheumatic fever. To report the prevalence, mortality and disability-adjusted life-years (DALY) due to RHD in the Middle East and North Africa (MENA) region from 1990 to 2019, by sex, age group, country and sociodemographic index (SDI). Information on the prevalence, mortality and DALY associated with RHD were obtained from the Global Burden of Disease Study 2019. Data were gathered for all countries in the MENA region over the period 1990–2019. These data included counts and age-standardized rates per 100,000, accompanied by 95% uncertainty intervals (UIs). The MENA region had an age-standardized point prevalence of 388.9 per 100,000 in 2019, which was 5.4% higher than in 1990. The annual incidence rate was 1.6, which was 63.4% lower than in 1990. There were 379.4 thousand DALY attributable to RHD in 2019, with an age-standardized rate of 67.1, which was 61.3% lower than in 1990. In 2019, an estimated 7.4 thousand deaths were due to RHD, and the age-standardized death rate was 63.4% lower in 2019 than in 1990. DALY rates rose steadily with increasing age in both males and females. The SDI correlated negatively with the rate of DALY for RHD throughout the study period. The burden of RHD in MENA declined from 1990 to 2019, demonstrating the importance of regularly updating health data and identifying risk factors, and developing effective guidelines on prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. burden of Alzheimer's disease and other types of dementia in the Middle East and North Africa region, 1990–2019.
- Author
-
Safiri, Saeid, Noori, Maryam, Nejadghaderi, Seyed Aria, Mousavi, Seyed Ehsan, Sullman, Mark J M, Araj-Khodaei, Mostafa, Collins, Gary S, Kolahi, Ali-Asghar, and Gharagozli, Kurosh
- Subjects
ALZHEIMER'S disease ,GLOBAL burden of disease ,AGE distribution ,LIFE expectancy ,SEX distribution ,DEMENTIA ,DESCRIPTIVE statistics ,SOCIODEMOGRAPHIC factors ,PEOPLE with disabilities ,DISEASE complications - Abstract
Background Alzheimer's disease (AD) is the most common cause of dementia and this progressive neurological disorder is associated with substantial mortality and morbidity. We aimed to report the burden of AD and other types of dementia in the Middle East and North Africa (MENA) region, by age, sex and sociodemographic index (SDI), for the period 1990–2019. Methods publicly accessible data on the prevalence, death and disability-adjusted life years (DALYs) because of AD, and other types of dementia, were retrieved from the global burden of disease 2019 project for all MENA countries from 1990 to 2019. Results in 2019, the age-standardised point prevalence of dementia was 777.6 per 100,000 populations in MENA, which was 3.0% higher than in 1990. The age-standardised death and DALY rates of dementia were 25.5 and 387.0 per 100,000, respectively. In 2019, the highest DALY rate was observed in Afghanistan and the lowest rate was in Egypt. That same year, the age-standardised point prevalence, death and DALY rates increased with advancing age and were higher for females of all age groups. From 1990 to 2019, the DALY rate of dementia decreased with increasing SDI up to 0.4, then slightly increased up to an SDI of 0.75, followed by a decrease for the remaining SDI levels. Conclusions the point prevalence of AD and other types of dementia has increased over the past three decades, and in 2019, the corresponding regional burden was higher than the global average. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019
- Author
-
Safiri, Saeid, Kolahi, Ali-Asghar, Naghavi, Mohsen, Nejadghaderi, Seyed Aria, Mansournia, Mohammad Ali, Sullman, Mark, Almasi-Hashiani, Amir, Sepidarkish, Mahdi, Ashrafi-Asgarabad, Ahad, Abdoli, Amir, Abu-Gharbieh, Eman, Advani, Shailesh M., Alahdab, Fares, Alipour, Vahid, Amini, Erfan, Anbesu, Etsay Woldu, Anderson, Jason A., Arabloo, Jalal, Awedew, Atalel Fentahun, Baig, Atif Amin, Bhagavathula, Akshaya Srikanth, Bijani, Ali, Biondi, Antonio, Bjørge, Tone, Braithwaite, Dejana, Caetano dos Santos, Florentino Luciano, Carreras, Giulia, Carvalho, Felix, Chu, Dinh-Toi, Compton, Kelly, Costa, Vera Marisa, Dai, Xiaochen, Dandona, Lalit, Dandona, Rakhi, Molla, Meseret Derbew, Desta, Abebaw Alemayehu, Dianatinasab, Mostafa, Ebrahimi, Hedyeh, Eftekharzadeh, Sahar, El Sayed, Iman, Eshrati, Babak, Farzadfar, Farshad, Feleke, Berhanu Elfu, Fernandes, Eduarda, Filip, Irina, Fomenkov, Artem Alekseevich, Gallus, Silvano, Ghafourifard, Mansour, Ghashghaee, Ahmad, Golechha, Mahaveer, Gonfa, Kebebe Bekele, Gorini, Giuseppe, Hafezi-Nejad, Nima, Hamidi, Samer, Harvey, James D., Hassanipour, Soheil, Hay, Simon I., Henrikson, Hannah Jacqueline, Househ, Mowafa, Ibitoye, Segun Emmanuel, Ilesanmi, Olayinka Stephen, Ilic, Irena M., Ilic, Milena D., Joukar, Farahnaz, Kumar, G. Anil, La Vecchia, Carlo, Ladi-Seyedian, Seyedeh-Sanam, Lami, Faris Hasan, Landires, Iván, Li, Bingyu, Lugo, Alessandra, Majeed, Azeem, Malekzadeh, Reza, Mestrovic, Tomislav, Miazgowski, Bartosz, Michalek, Irmina Maria, Moghadaszadeh, Masoud, Mohamad, Osama, Mohammadian-Hafshejani, Abdollah, Reza, Mohammadpourhodki, Mohammed, Shafiu, Mokdad, Ali H., Molokhia, Mariam, Monasta, Lorenzo, Moradzadeh, Rahmatollah, Nabavizadeh, Behnam, Naimzada, Mukhammad David, Nguyen, Cuong Tat, Nguyen, Huong Lan Thi, Nikbakhsh, Rajan, Nowroozi, Mohammad Reza, Nuñez-Samudio, Virginia, Otstavnov, Stanislav S., Pham, Hai Quang, Pirestani, Majid, Pottoo, Faheem Hyder, Rabiee, Navid, Radfar, Amir, Rafiei, Alireza, Rathi, Priya, Rawaf, David Laith, Rawaf, Salman, Rezaei, Nima, Roberts, Nicholas L.S., Roshandel, Gholamreza, Samy, Abdallah M., Sepanlou, Sadaf G., Sha, Feng, Shaikh, Masood Ali, Sheikhbahaei, Sara, Malleshappa, Sudeep K. Siddappa, Singh, Jasvinder A., Spurlock, Emma Elizabeth, Tadesse, Eyayou Girma, Tefera, Yonas Getaye, Tekalegn, Yohannes, Titova, Mariya Vladimirovna, Topor-Madry, Roman, Traini, Eugenio, Tran, Bach Xuan, Tran, Khanh Bao, Travillian, Ravensara S., Vacante, Marco, Xu, Rixing, Yeshitila, Yordanos Gizachew, Zadnik, Vesna, Zamanian, Maryam, and Zhang, Zhi-Jiang
- Subjects
Male ,Medicine (General) ,Sociodemographic Factors ,ALCOHOL-CONSUMPTION ,Population ,Infectious and parasitic diseases ,RC109-216 ,Global Burden of Disease Bladder Cancer Collaborators ,Global Burden of Disease ,R5-920 ,Risk Factors ,Medicine ,cancer ,Humans ,education ,METAANALYSIS ,VEGETABLES ,Bladder cancer ,Epidemiology ,Global burden ,Public, Environmental & Occupational Health ,Cause of death ,Original Research ,education.field_of_study ,Science & Technology ,TEA ,FRUIT ,business.industry ,MORTALITY ,Health Policy ,Incidence (epidemiology) ,Mortality rate ,Public Health, Environmental and Occupational Health ,Disability-Adjusted Life Years ,ASSOCIATION ,medicine.disease ,Years of potential life lost ,Urinary Bladder Neoplasms ,Attributable risk ,Life expectancy ,epidemiology ,Female ,Quality-Adjusted Life Years ,business ,Life Sciences & Biomedicine ,Demography - Abstract
IntroductionThe current study determined the level and trends associated with the incidence, death and disability rates for bladder cancer and its attributable risk factors in 204 countries and territories, from 1990 to 2019, by age, sex and sociodemographic index (SDI; a composite measure of sociodemographic factors).MethodsVarious data sources from different countries, including vital registration and cancer registries were used to generate estimates. Mortality data and incidence data transformed to mortality estimates using the mortality to incidence ratio (MIR) were used in a cause of death ensemble model to estimate mortality. Mortality estimates were divided by the MIR to produce incidence estimates. Prevalence was calculated using incidence and MIR-based survival estimates. Age-specific mortality and standardised life expectancy were used to estimate years of life lost (YLLs). Prevalence was multiplied by disability weights to estimate years lived with disability (YLDs), while disability-adjusted life years (DALYs) are the sum of the YLLs and YLDs. All estimates were presented as counts and age-standardised rates per 100 000 population.ResultsGlobally, there were 524 000 bladder cancer incident cases (95% uncertainty interval 476 000 to 569 000) and 229 000 bladder cancer deaths (211 000 to 243 000) in 2019. Age-standardised death rate decreased by 15.7% (8.6 to 21.0), during the period 1990–2019. Bladder cancer accounted for 4.39 million (4.09 to 4.70) DALYs in 2019, and the age-standardised DALY rate decreased significantly by 18.6% (11.2 to 24.3) during the period 1990–2019. In 2019, Monaco had the highest age-standardised incidence rate (31.9 cases (23.3 to 56.9) per 100 000), while Lebanon had the highest age-standardised death rate (10.4 (8.1 to 13.7)). Cabo Verde had the highest increase in age-standardised incidence (284.2% (214.1 to 362.8)) and death rates (190.3% (139.3 to 251.1)) between 1990 and 2019. In 2019, the global age-standardised incidence and death rates were higher among males than females, across all age groups and peaked in the 95+ age group. Globally, 36.8% (28.5 to 44.0) of bladder cancer DALYs were attributable to smoking, more so in males than females (43.7% (34.0 to 51.8) vs 15.2% (10.9 to 19.4)). In addition, 9.1% (1.9 to 19.6) of the DALYs were attributable to elevated fasting plasma glucose (FPG) (males 9.3% (1.6 to 20.9); females 8.4% (1.6 to 19.1)).ConclusionsThere was considerable variation in the burden of bladder cancer between countries during the period 1990–2019. Although there was a clear global decrease in the age-standardised death, and DALY rates, some countries experienced an increase in these rates. National policy makers should learn from these differences, and allocate resources for preventative measures, based on their country-specific estimates. In addition, smoking and elevated FPG play an important role in the burden of bladder cancer and need to be addressed with prevention programmes.
- Published
- 2021
7. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
- Author
-
Safiri, Saeid, Nejadghaderi, Seyed Aria, Karamzad, Nahid, Kaufman, Jay S., Carson-Chahhoud, Kristin, Bragazzi, Nicola Luigi, Sullman, Mark J. M., Beyranvand, Mohammad Reza, Mansournia, Mohammad Ali, Almasi-Hashiani, Amir, Collins, Gary S., and Kolahi, Ali-Asghar
- Subjects
BLOOD sugar ,GLOBAL burden of disease ,AGE groups ,DEATH rate ,DEVELOPED countries - Abstract
Background: To report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019 for 204 countries and territories. Methods: Using the Comparative Risk Assessment approach of Global Burden of Disease (GBD) study 2019, the burden of cancers attributable to HFPG was reported in 1990 and 2019. Results: Globally, in 2019 there were an estimated 419.3 thousand cancer deaths (95% UI: 115.7 to 848.5) and 8.6 million cancer DALYs (2.4 to 17.6) attributable to HFPG. By sex, 4.6 (1.1 to 9.9) and 4.0 (1.1 to 8.4) million global cancer DALYs were attributable to HFPG in men and women, respectively. The global age-standardized death and DALY rates of cancers attributable to HFPG (per 100,000) have increased by 27.8% (20.5 to 38.7%) and 24.5% (16.4 to 35.6%), respectively, since 1990. High-income North America (9.5 [2.7 to 18.8]) and Eastern Sub-Saharan Africa (2.0 [0.5 to 4.2]) had the highest and lowest regional age-standardized death rates, respectively, for cancers attributable to HFPG. In 2019, the global number of attributable cancer DALYs were highest in 65-69 age group. Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for HFPG-attributable cancers. Conclusions: HFPG was associated with more burden in 2019. Preventive programs for diabetes and screening of individuals with diabetes for cancers, especially in older males living in developed countries, are required to arrest the large increases in HFPGattributable cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019.
- Author
-
Safiri, Saeid, Karamzad, Nahid, Kaufman, Jay S., Bell, Arielle Wilder, Nejadghaderi, Seyed Aria, Sullman, Mark J. M., Moradi-Lakeh, Maziar, Collins, Gary, and Kolahi, Ali-Asghar
- Subjects
TYPE 2 diabetes ,GLOBAL burden of disease ,NON-communicable diseases ,BODY mass index - Abstract
Aim: To report the point prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories during the period 1990-2019. Methods: We used the data of the Global Burden of Disease (GBD) Study 2019 to report number and age-standardised rates per 100 000 population of type 2 diabetes. Estimates were reported with 95% uncertainty intervals (UIs). Results: In 2019, the global age-standardised point prevalence and death rates for type 2 diabetes were 5282.9 and 18.5 per 100 000, an increase of 49% and 10.8%, respectively, since 1990. Moreover, the global age-standardised DALY rate in 2019 was 801.5 per 100 000, an increase of 27.6% since 1990. In 2019, the global point prevalence of type 2 diabetes was slightly higher in males and increased with age up to the 75-79 age group, decreasing across the remaining age groups. American Samoa [19876.8] had the highest age-standardised point prevalence rates of type 2 diabetes in 2019. Generally, the burden of type 2 diabetes decreased with increasing SDI (Socio-demographic Index). Globally, high body mass index [51.9%], ambient particulate matter pollution [13.6%] and smoking [9.9%] had the three highest proportions of attributable DALYs. Conclusion: Low and middle-income countries have the highest burden and greater investment in type 2 diabetes prevention is needed. In addition, accurate data on type 2 diabetes needs to be collected by the health systems of all countries to allow better monitoring and evaluation of population-level interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019.
- Author
-
Safiri, Saeid, Carson-Chahhoud, Kristin, Karamzad, Nahid, Sullman, Mark J.M., Nejadghaderi, Seyed Aria, Taghizadieh, Ali, Bell, Arielle Wilder, Kolahi, Ali-Asghar, Ansarin, Khalil, Mansournia, Mohammad Ali, Collins, Gary S., and Kaufman, Jay S.
- Subjects
WHEEZE ,GLOBAL burden of disease ,ASTHMA - Abstract
Background: Understanding global trends in the point prevalence, deaths, and disability-adjusted life-years (DALYs) for asthma will facilitate evidence-based decision-making.Research Question: What are the global, regional, and national burdens of asthma in 204 countries and territories between 1990 and 2019 by age, sex, and sociodemographic index (SDI)?Study Design and Methods: Publicly available data from the Global Burden of Disease study from 1990 through 2019 were used. All estimates were presented as counts and age-standardized rates per 100,000, along with their associated uncertainty intervals.Results: In 2019, the global age-standardized point prevalence and death rates for asthma were 3,415.5 and 5.8 per 100,000, which represent a 24% and 51.3% decrease since 1990, respectively. Moreover, in 2019, the global age-standardized DALY rate was 273.6 and the global point prevalence of asthma was highest in the group 5 to 9 years of age. Also in 2019, the United States (10,399.3) showed the highest age-standardized point prevalence rate of asthma. Generally, the burden of asthma decreased with increasing SDI. Globally, high BMI (16.9%), smoking (9.9%), and occupational asthmagens (8.8%) contributed to the 2019 asthma DALYs.Interpretation: Asthma remains an important public health issue, particularly in regions with low socioeconomic development. Future research is needed to examine thoroughly the associations asthma has with its risk factors and the factors impeding optimal self-management. Further research also is needed to understand and implement better the interventions that have reduced the burden of asthma. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Burden of Transport-Related Injuries in the Eastern Mediterranean Region: A Systematic Analysis for the Global Burden of Disease Study 2017.
- Author
-
Safiri, Saeid, Sullman, Mark J. M., Lajunen, Timo, Hill, Tetiana, Almasi-Hashiani, Amir, Moradi-Lakeh, Maziar, Farzadfar, Farshad, Sepanlou, Sadaf G., Abu-Gharbieh, Eman, Aghamolaei, Teamur, Ahmad, Tauseef, Alghnam, Suliman A., Al-Hajj, Samar, Alipour, Vahid, Aljunid, Syed Mohamed, Anjomshoa, Mina, Ansari-Moghaddam, Alireza, Arabloo, Jalal, Bayati, Mohsen, and Bedi, Neeraj
- Subjects
- *
CAUSES of death , *TRAFFIC accidents , *AGE distribution , *LIFE expectancy , *SEX distribution , *DESCRIPTIVE statistics , *WOUNDS & injuries , *PEOPLE with disabilities - Abstract
Background: Transport-related injuries (TIs) are a substantial public health concern for all regions of the world. The present study quantified the burden of TIs and deaths in the Eastern Mediterranean region (EMR) in 2017 by sex and age. Methods: TIs and deaths were estimated by age, sex, country, and year using Cause of Death Ensemble modelling (CODEm) and DisMod-MR 2.1. Disability-adjusted life years (DALYs), which quantify the total burden of years lost due to premature death or disability, were also estimated per 100 000 population. All estimates were reported along with their corresponding 95% uncertainty intervals (UIs). Results: In 2017, there were 5.5 million (UI 4.9-6.2) transport-related incident cases in the EMR -- a substantial increase from 1990 (2.8 million; UI 2.5-3.1). The age-standardized incidence rate for the EMR in 2017 was 787 (UI 705.5-876.2) per 100 000, which has not changed significantly since 1990 (-0.9%; UI -4.7 to 3). These rates differed remarkably between countries, such that Oman (1303.9; UI 1167.3-1441.5) and Palestine (486.5; UI 434.5-545.9) had the highest and lowest age-standardized incidence rates per 100 000, respectively. In 2017, there were 185.3 thousand (UI 170.8-200.6) transport-related fatalities in the EMR -- a substantial increase since 1990 (140.4 thousand; UI 118.7-156.9). The age-standardized death rate for the EMR in 2017 was 29.5 (UI 27.1-31.9) per 100 000, which was 30.5% lower than that found in 1990 (42.5; UI 36.8-47.3). In 2017, Somalia (54; UI 30-77.4) and Lebanon (7.1; UI 4.8-8.6) had the highest and lowest age-standardized death rates per 100,000, respectively. The age-standardised DALY rate for the EMR in 2017 was 1,528.8 (UI 1412.5-1651.3) per 100 000, which was 34.4% lower than that found in 1990 (2,331.3; UI 1,993.1-2,589.9). In 2017, the highest DALY rate was found in Pakistan (3 454 121; UI 2 297 890-4 342 908) and the lowest was found in Bahrain (8616; UI 7670-9751). Conclusion: The present study shows that while road traffic has become relatively safer (measured by deaths and DALYs per 100 000 population), the number of transport-related fatalities in the EMR is growing and needs to be addressed urgently. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017.
- Author
-
Safiri, Saeid, Kolahi, Ali-Asghar, Mansournia, Mohammad Ali, Almasi-Hashiani, Amir, Ashrafi-Asgarabad, Ahad, Sullman, Mark J. M., Bettampadi, Deepti, Qorbani, Mostafa, Moradi-Lakeh, Maziar, Ardalan, Mohammadreza, Mokdad, Ali, and Fitzmaurice, Christina
- Subjects
RENAL cancer ,DISEASE risk factors ,MORTALITY ,DEATH rate ,BODY mass index ,SMOKING - Abstract
Kidney cancer globally accounts for more than 131,000 deaths each year and has been found to place a large economic burden on society. However, there are no recent articles on the burden of kidney cancer across the world. The aim of this study was to present a status report on the incidence, mortality and disability-adjusted life years (DALYs) associated with kidney cancer in 195 countries, from 1990 to 2017. Vital registration and cancer registry data (total of 23,660 site-years) were used to generate the estimates. Mortality was estimated first and the incidence and DALYs were calculated based on the estimated mortality values. All estimates were presented as counts and age-standardised rates per 100,000 population. The estimated rates were calculated by age, sex and according to the Socio-Demographic Index (SDI). In 2017, kidney cancer accounted for 393.0 thousand (95% UI: 371.0–404.6) incident cases, 138.5 thousand (95% UI: 128.7–142.5) deaths and 3.3 million (95% UI: 3.1–3.4) DALYs globally. The global age-standardised rates for the incidence, deaths and DALY were 4.9 (95% UI: 4.7–5.1), 1.7 (95% UI: 1.6–1.8) and 41.1 (95% UI: 38.7–42.5), respectively. Uruguay [15.8 (95% UI: 13.6–19.0)] and Bangladesh [1.5 (95% UI: 1.0–1.8)] had highest and lowest age-standardised incidence rates, respectively. The age-standardised death rates varied substantially from 0.47 (95% UI: 0.34–0.58) in Bangladesh to 5.6 (95% UI: 4.6–6.1) in the Czech Republic. Incidence and mortality rates were higher among males, than females, across all age groups, with the highest rates for both sexes being observed in the 95+ age group. Generally, positive associations were found between each country's age-standardised DALY rate and their corresponding SDI. The considerable burden of kidney cancer was attributable to high body mass index (18.5%) and smoking (16.6%) in both sexes. There are large inter-country differences in the burden of kidney cancer and it is generally higher in countries with a high SDI. The findings from this study provide much needed information for those in each country that are making health-related decisions about priority areas, resource allocation, and the effectiveness of prevention programmes. The results of our study also highlight the need for renewed efforts to reduce exposure to the kidney cancer risk factors and to improve the prevention and the early detection of this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
12. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019
- Author
-
Kristin Carson-Chahhoud, Gary S. Collins, Ali Taghizadieh, Jay S. Kaufman, Arielle Wilder Bell, Mark J.M. Sullman, Ali-Asghar Kolahi, Seyed Aria Nejadghaderi, Mohammad Ali Mansournia, Khalil Ansarin, Saeid Safiri, Nahid Karamzad, Safiri, Saeid, Carson-Chahhoud, Kristin, Karamzad, Nahid, Sullman, Mark JM, Nejadghaderi, Seyed Aria, Taghizadieh, Ali, Bell, Arielle Wilder, Kolahi, Ali-Asghar, Ansarin, Khalil, Mansournia, Mohammad Ali, Collins, Gary S, and Kaufman, Jay S
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,prevalence ,Prevalence ,Global Health ,Critical Care and Intensive Care Medicine ,burden ,Risk Factors ,Environmental health ,Epidemiology ,medicine ,Humans ,risk factors ,Disability-adjusted life year ,Asthma ,business.industry ,Public health ,Mortality rate ,Disability-Adjusted Life Years ,asthma ,global ,medicine.disease ,mortality ,Years of potential life lost ,Attributable risk ,Female ,epidemiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Understanding global trends in the point prevalence, deaths and disability adjusted life years (DALYs) for asthma will facilitate evidence-based decision making. Research Question What is the global, regional and national burden of asthma in 204 countries and territories between 1990 and 2019, by age, sex and socio-demographic index (SDI)? Study Design and Methods Publicly available data from the Global Burden of Disease study were used over the period 1990 to 2019. All estimates were presented as counts and age-standardised rates per 100,000, along with their associated uncertainty intervals (UIs). Results In 2019, the global age-standardised point prevalence and death rates for asthma were 3415.5 and 5.8 per 100,000, which represent a 24% and 51.3% decrease since 1990, respectively. Moreover, in 2019 the global age-standardised DALY rate was 273.6 and the global point prevalence of asthma was highest in the 5-9 age group. Also in 2019, the USA (10399.3) had the highest age-standardised point prevalence rate of asthma. Generally, the burden of asthma decreased with increasing socio-demographic index (SDI). Globally, high body mass index (16.9%), smoking (9.9%) and occupational asthmagens (8.8%) contributed to the 2019 asthma DALYs. Interpretation Asthma remains an important public health issue, particularly in regions with low socio-economic development. Future research is needed to thoroughly examine the associations asthma has with its risk factors and the factors impeding optimal self-management. Further research is also needed to understand and better implement the interventions that have reduced the burden of asthma.
- Published
- 2022
13. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019
- Author
-
Saeid Safiri, Seyed Aria Nejadghaderi, Nahid Karamzad, Jay S. Kaufman, Kristin Carson-Chahhoud, Nicola Luigi Bragazzi, Mark J. M. Sullman, Mohammad Reza Beyranvand, Mohammad Ali Mansournia, Amir Almasi-Hashiani, Gary S. Collins, Ali-Asghar Kolahi, Safiri, Saeid, Nejadghaderi, Seyed Aria, Karamzad, Nahid, Kaufman, Jay S, Carson-Chahhoud, Kristin, Bragazzi, Nicola Luigi, Sullman, Mark JM, Beyranvand, Mohammad Reza, Mansournia, Mohammad Ali, Almasi-Hashiani, Amir, Collins, Gary S, and Kolahi, Ali Asghar
- Subjects
Blood Glucose ,Male ,Endocrinology, Diabetes and Metabolism ,neoplasms ,Fasting ,mortality ,Global Burden of Disease ,Neoplasms ,diabetes mellitus ,incidence ,Diabetes Mellitus ,Humans ,epidemiology ,Female ,Quality-Adjusted Life Years ,Aged - Abstract
BackgroundTo report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019 for 204 countries and territories.MethodsUsing the Comparative Risk Assessment approach of Global Burden of Disease (GBD) study 2019, the burden of cancers attributable to HFPG was reported in 1990 and 2019.ResultsGlobally, in 2019 there were an estimated 419.3 thousand cancer deaths (95% UI: 115.7 to 848.5) and 8.6 million cancer DALYs (2.4 to 17.6) attributable to HFPG. By sex, 4.6 (1.1 to 9.9) and 4.0 (1.1 to 8.4) million global cancer DALYs were attributable to HFPG in men and women, respectively. The global age-standardized death and DALY rates of cancers attributable to HFPG (per 100,000) have increased by 27.8% (20.5 to 38.7%) and 24.5% (16.4 to 35.6%), respectively, since 1990. High-income North America (9.5 [2.7 to 18.8]) and Eastern Sub-Saharan Africa (2.0 [0.5 to 4.2]) had the highest and lowest regional age-standardized death rates, respectively, for cancers attributable to HFPG. In 2019, the global number of attributable cancer DALYs were highest in 65-69 age group. Moreover, there was an overall positive association between SDI and the regional age-standardized DALY rate for HFPG-attributable cancers.ConclusionsHFPG was associated with more burden in 2019. Preventive programs for diabetes and screening of individuals with diabetes for cancers, especially in older males living in developed countries, are required to arrest the large increases in HFPG-attributable cancers.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.